GVI phospholipase A2 role in the stimulatory effect of sphingosine-1-phosphate on TRPC5 cationic channels

Cell Calcium

Volumn 50, Issue 4, 2011, Pages 343-350

  AL Shawaf, Eman ^a   Tumova, Sarka ^a   Naylor, Jacqueline ^a   Majeed, Yasser ^a   Li, Jing ^a   Beech, David J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Calcium permeable channel; Cationic channel; Lysophosphatidylcholine; Phospholipase; Sphingosine 1 phosphate; Transient receptor potential

Indexed keywords

ARACHIDONIC ACID; BROMOENOL LACTONE; CALCIUM ION; GADOLINIUM; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2 GROUP VI; SPHINGOSINE 1 PHOSPHATE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRITIUM;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL STRAIN HEK293; CHANNEL GATING; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; WHOLE CELL;

EID: 80053296353     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2011.06.003     Document Type: Article

References (56)

1. 2+-permeable nonselective cation channels. Cell Calcium 2003, 33:441-450.
2. Jiang L.H., Gamper N., Beech D.J. Properties and therapeutic potential of transient receptor potential channels with putative roles in adversity: focus on TRPC5, TRPM2 and TRPA1. Curr. Drug Targets 2011.
3. Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol. Rev. 2007, 87:165-217.
4. Abramowitz J., Birnbaumer L. Physiology and pathophysiology of canonical transient receptor potential channels. Faseb J. 2009, 23:297-328.
5. Greka A., Navarro B., Oancea E., Duggan A., Clapham D.E. TRPC5 is a regulator of hippocampal neurite length and growth cone morphology. Nat. Neurosci. 2003, 6:837-845.
6. Nath A.K., Krauthammer M., Li P., Davidov E., Butler L.C., Copel J., Katajamaa M., Oresic M., Buhimschi I., Buhimschi C., Snyder M., Madri J.A. Proteomic-based detection of a protein cluster dysregulated during cardiovascular development identifies biomarkers of congenital heart defects. PLoS ONE 2009, 4:e4221.
7. Riccio A., Li Y., Moon J., Kim K.S., Smith K.S., Rudolph U., Gapon S., Yao G.L., Tsvetkov E., Rodig S.J., Van't Veer A., Meloni E.G., Carlezon W.A., Bolshakov V.Y., Clapham D.E. Essential role for TRPC5 in amygdala function and fear-related behavior. Cell 2009, 137:761-772.
8. Xu S.Z., Muraki K., Zeng F., Li J., Sukumar P., Shah S., Dedman A.M., Flemming P.K., McHugh D., Naylor J., Cheong A., Bateson A.N., Munsch C.M., Porter K.E., Beech D.J. A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. Circ. Res. 2006, 98:1381-1389.
9. 2+ channel from mouse brain. J. Biol. Chem. 1998, 273:10279-10287.
10. Schaefer M., Plant T.D., Obukhov A.G., Hofmann T., Gudermann T., Schultz G. Receptor-mediated regulation of the nonselective cation channels TRPC4 and TRPC5. J. Biol. Chem. 2000, 275:17517-17526.
11. Venkatachalam K., Zheng F., Gill D.L. Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J. Biol. Chem. 2003, 278:29031-29040.
12. Zeng F., Xu S.Z., Jackson P.K., McHugh D., Kumar B., Fountain S.J., Beech D.J. Human TRPC5 channel activated by a multiplicity of signals in a single cell. J. Physiol. 2004, 559:739-750.
13. Kanki H., Kinoshita M., Akaike A., Satoh M., Mori Y., Kaneko S. Activation of inositol 1,4,5-trisphosphate receptor is essential for the opening of mouse TRP5 channels. Mol. Pharmacol. 2001, 60:989-998.
14. Lee Y.M., Kim B.J., Kim H.J., Yang D.K., Zhu M.H., Lee K.P., So I., Kim K.W. TRPC5 as a candidate for the nonselective cation channel activated by muscarinic stimulation in murine stomach. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G604-G616.
15. Al-Shawaf E., Naylor J., Taylor H., Riches K., Milligan C.J., O'Regan D., Porter K.E., Li J., Beech D.J. Short-term stimulation of calcium-permeable transient receptor potential canonical 5-containing channels by oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1453-1459.
16. Jung S., Muhle A., Schaefer M., Strotmann R., Schultz G., Plant T.D. Lanthanides potentiate TRPC5 currents by an action at extracellular sites close to the pore mouth. J. Biol. Chem. 2003, 278:3562-3571.
17. Flemming P.K., Dedman A.M., Xu S.Z., Li J., Zeng F., Naylor J., Benham C.D., Bateson A.N., Muraki K., Beech D.J. Sensing of lysophospholipids by TRPC5 calcium channel. J. Biol. Chem. 2006, 281:4977-4982.
18. Semtner M., Schaefer M., Pinkenburg O., Plant T.D. Potentiation of TRPC5 by protons. J. Biol. Chem. 2007, 282:33868-33878.
19. Xu S.Z., Sukumar P., Zeng F., Li J., Jairaman A., English A., Naylor J., Ciurtin C., Majeed Y., Milligan C.J., Bahnasi Y.M., Al-Shawaf E., Porter K.E., Jiang L.H., Emery P., Sivaprasadarao A., Beech D.J. TRPC channel activation by extracellular thioredoxin. Nature 2008, 451:69-72.
20. Beech D., Bahnasi Y.M., Dedman A.M., AL-Shawaf E. TRPC channel lipid specificity and mechanisms of lipid regulation. Cell Calcium 2009, 45:583-588.
21. Wolf M.J., Wang J., Turk J., Gross R.W. Depletion of intracellular calcium stores activates smooth muscle cell calcium-independent phospholipase A2. A novel mechanism underlying arachidonic acid mobilization. J. Biol. Chem. 1997, 272:1522-1526.
22. Vasta V., Meacci E., Catarzi S., Donati C., Farnararo M., Bruni P. Sphingosine 1-phosphate induces arachidonic acid mobilization in A549 human lung adenocarcinoma cells. Biochim. Biophys. Acta 2000, 1483:154-160.
23. Schaloske R.H., Dennis E.A. The phospholipase A2 superfamily and its group numbering system. Biochim. Biophys. Acta 2006, 1761:1246-1259.
24. Balsinde J., Perez R., Balboa M.A. Calcium-independent phospholipase A2 and apoptosis. Biochim. Biophys. Acta 2006, 1761:1344-1350.
25. 2+-independent phospholipase A2 isoforms in oxidant-induced neural cell death. Neurotoxicology 2007, 28:150-160.
26. Herbert S.P., Ponnambalam S., Walker J.H. Cytosolic phospholipase A2-alpha mediates endothelial cell proliferation and is inactivated by association with the Golgi apparatus. Mol. Biol. Cell 2005, 16:3800-3809.
27. Herbert S.P., Odell A.F., Ponnambalam S., Walker J.H. Activation of cytosolic phospholipase A2-{alpha} as a novel mechanism regulating endothelial cell cycle progression and angiogenesis. J. Biol. Chem. 2009, 284:5784-5796.
28. Jenkins C.M., Han X., Mancuso D.J., Gross R.W. Identification of calcium-independent phospholipase A2 (iPLA2) beta, and not iPLA2gamma, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells. Enantioselective mechanism-based discrimination of mammalian iPLA2s. J. Biol. Chem. 2002, 277:32807-32814.
29. Naylor J., Al-Shawaf E., McKeown L., Manna P.T., Porter K.E., O'Regan D., Muraki K., Beech D.J. TRPC5 channel sensitivities to antioxidants and hydroxylated stilbenes. J. Biol. Chem. 2011, 286:5078-5086.
30. Obukhov A.G., Nowycky M.C. TRPC5 channels undergo changes in gating properties during the activation-deactivation cycle. J. Cell. Physiol. 2008, 216:162-171.
31. Obukhov A.G., Nowycky M.C. TRPC5 activation kinetics are modulated by the scaffolding protein ezrin/radixin/moesin-binding phosphoprotein-50 (EBP50). J. Cell. Physiol. 2004, 201:227-235.
32. Herbert S.P., Walker J.H. Group VIA calcium-independent phospholipase A2 mediates endothelial cell S phase progression. J. Biol. Chem. 2006, 281:35709-35716.
33. 2+-independent phospholipase A2-dependent gating of TRPM8 by lysophospholipids. J. Biol. Chem. 2006, 281:40174-40182.
34. Andersson D.A., Nash M., Bevan S. Modulation of the cold-activated channel TRPM8 by lysophospholipids and polyunsaturated fatty acids. J. Neurosci. 2007, 27:3347-3355.
35. Smani T., Zakharov S.I., Csutora P., Leno E., Trepakova E.S., Bolotina V.M. A novel mechanism for the store-operated calcium influx pathway. Nat. Cell Biol. 2004, 6:113-120.
36. 2+ current and M-current by divergent signal transduction cascades. J. Neurosci. 2006, 26:11588-11598.
37. Eder P., Poteser M., Romanin C., Groschner K. Na(+) entry and modulation of Na(+)/Ca(2+) exchange as a key mechanism of TRPC signaling. Pflugers Arch. 2005, 451:99-104.
38. Gamper N., Shapiro M.S. Regulation of ion transport proteins by membrane phosphoinositides. Nat. Rev. Neurosci. 2007, 8:921-934.
39. Miehe S., Bieberstein A., Arnould I., Ihdene O., Rutten H., Strubing C. The phospholipid-binding protein SESTD1 is a novel regulator of the transient receptor potential channels TRPC4 and TRPC5. J. Biol. Chem. 2010, 285:12426-12434.
40. Kim B.J., Kim M.T., Jeon J.H., Kim S.J., So I. Involvement of phosphatidylinositol 4,5-bisphosphate in the desensitization of canonical transient receptor potential 5. Biol. Pharm. Bull. 2008, 31:1733-1738.
41. Trebak M., Lemonnier L., Dehaven W.I., Wedel B.J., Bird G.S., Putney J.W. Complex functions of phosphatidylinositol 4,5-bisphosphate in regulation of TRPC5 cation channels. Pflugers Arch. 2009, 457:757-769.
42. Otsuguro K., Tang J., Tang Y., Xiao R., Freichel M., Tsvilovskyy V., Ito S., Flockerzi V., Zhu M.X., Zholos A.V. Isoform-specific inhibition of TRPC4 channel by phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem. 2008, 283:10026-10036.
43. Strubing C., Krapivinsky G., Krapivinsky L., Clapham D.E. TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron 2001, 29:645-655.
44. Xu S.Z., Zeng F., Boulay G., Grimm C., Harteneck C., Beech D.J. Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br. J. Pharmacol. 2005, 145:405-414.
45. Zhu M.H., Chae M., Kim H.J., Lee Y.M., Kim M.J., Jin N.G., Yang D.K., So I., Kim K.W. Desensitization of canonical transient receptor potential channel 5 by protein kinase C. Am. J. Physiol. Cell Physiol. 2005, 289:C591-C600.
46. Hui H., McHugh D., Hannan M., Zeng F., Xu S.Z., Khan S.U., Levenson R., Beech D.J., Weiss J.L. Calcium-sensing mechanism in TRPC5 channels contributing to retardation of neurite outgrowth. J. Physiol. 2006, 572:165-172.
47. Blair N.T., Kaczmarek J.S., Clapham D.E. Intracellular calcium strongly potentiates agonist-activated TRPC5 channels. J. Gen. Physiol. 2009, 133:525-546.
48. 2+-selective ion channels. J. Biol. Chem. 2009, 284:34423-34432.
49. Cummings B.S., McHowat J., Schnellmann R.G. Role of an endoplasmic reticulum Ca(2+)-independent phospholipase A(2) in oxidant-induced renal cell death. Am. J. Physiol. Renal Physiol. 2002, 283:F492-F498.
50. Carper M.J., Zhang S., Turk J., Ramanadham S. Skeletal muscle group VIA phospholipase A2 (iPLA2beta): expression and role in fatty acid oxidation. Biochemistry 2008, 47:12241-12249.
51. Malhotra A., Edelman-Novemsky I., Xu Y., Plesken H., Ma J., Schlame M., Ren M. Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome. Proc. Natl. Acad. Sci. U.S.A. 2009.
52. Hazen S.L., Gross R.W. Identification and characterization of human myocardial phospholipase A2 from transplant recipients suffering from end-stage ischemic heart disease. Circ. Res. 1992, 70:486-495.
53. Forlenza O.V., Mendes C.T., Marie S.K., Gattaz W.F. Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76:47-55.
54. White M.C., McHowat J. Protease activation of calcium-independent phospholipase A2 leads to neutrophil recruitment to coronary artery endothelial cells. Thromb. Res. 2007, 120:597-605.
55. Xie Z., Gong M.C., Su W., Turk J., Guo Z. Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells. J. Biol. Chem. 2007, 282:25278-25289.
56. 2+ entry and vascular tone in intact aorta. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2466-H2474.